In 2012, there were 14 million cases of cancer globally. This number is expected to nearly double to 24 million by 2035, driven by a world population that is aging into higher cancer prevalence rates.
The growth in cancer cases will be a major financial burden on governments. Today, the estimated global spend on cancer care is about $0.5 Trillion. The cost of years lost from ill-health, disability, or death due to cancer outweighs all other health concerns
Cancer treatment typically involves the use of Chemotherapy and/or Radiotherapy as part of the treatment plan. While these therapies are considered to be cost-effective, they often also have significant unwanted side effects – often serious enough that patients will underutilize these therapies due to quality of life concerns. An estimated $40 Billion a year is spent globally in supportive care as a result of the side effects of cancer therapy. In the US, this care averages $6,587 per cancer patient.
C.A.R.E. RadioImmunotherapy is a patented and copyright protected protocol that significantly reduces the unwanted side effects of Chemotherapy and Radiotherapy. It has the potential to save a significant portion of supportive care costs, while at the same time significantly improving the quality of life for the approximately half of all cancer patients who have well-defined tumors and utilize chemo or radiation.
Pre-clinical and clinical research shows that C.A.R.E. RadioImmunotherapy offers 3 primary benefits:
The addressable market for C.A.R.E. RadioImmunotherapy is estimated to be more than $11 Billion globally, growing at 6.2% CAGR, with the largest markets being Europe, East/Central Asia, and North America. Radiation Barrier will address these markets by deploying C.A.R.E. RadioImmunotherapy clinics clustered near Chemo infusion centers and high-dose Radiotherapy facilities globally.
C.A.R.E. RadioImmunotherapy complements other cancer therapies because it acts directly at the cellular level to reduce cellular toxicity to healthy cells.
Achievements to Date:
If you are interested in learning more about investing in Radiation Barrier and learning more, please contact us.
*2014 Economics of Cancer prevention study